Bone tissue content of TGF-β₂ changes with time in human heterotopic ossification after total hip arthroplasty

References

• Abrahamsson SO, Ahlgren SA, Dahlström JA, Ohlin P, Stigsson L. Ectopic bone after hip replacement. Excision and free fat transplants in four cases. Acta Orthop Scand 1984; 55: 589–592
   PubMed Web of Science ®Google Scholar
• Bartlett CS, Rapuano BE, Lorich DG, Wu T, Anderson RC, Tomin E, Hsu JF, Lane JM, Helfet DL. Early changes in prostaglandins precede bone formation in a rabbit model of heterotopic ossification. Bone 2006; 38: 322–332
   PubMedGoogle Scholar
• Bonewald LF. Transforming growth factor-β. Principles of bone biology2nd ed., JP Bilezikian, LG Raisz, GA Rodan. Academic Press, New York 2002; Vol. 1: 903–918
   Google Scholar
• Bosse A, Wulf M, Wiethege T, Voss B, Müller KM. Collagens and growth factors in heterotopic ossification. Pathology 1994; 15: 216–225
   Google Scholar
• Cho TJ, Gerstenfeld LC. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 2002; 17: 513–520
   PubMed Web of Science ®Google Scholar
• De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, Vivarelli M, Muratori F, Berni S, Ballanti P, Ferrari S, Teti A. Impaired skeletal development in interleukin-6-transgenic mice: A model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum 2006; 54: 3551–3563
   PubMed Web of Science ®Google Scholar
• Huojia M, Muraoka N, Yoshizaki K, Fukumoto S, Nakashima M, Akamine A, Nonaka K, Ohishi M. TGF-beta3 induces ectopic mineralization in fetal mouse dental pulp during tooth germ development. Dev Growth Differ 2005; 47: 141–152
   PubMed Web of Science ®Google Scholar
• Iorio R, Healy WL. Heterotopic ossification after hip and knee arthroplasty: Risk factors, prevention, and treatment. J Am Acad Orthop Surg 2002; 10: 409–416
   PubMedGoogle Scholar
• Joyce ME, Roberts AB, Sporn MB, Bolander ME. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 1990; 110: 2195–2207
   PubMed Web of Science ®Google Scholar
• Kiernan JA. Heidenhain's AZAN. Histological & histochemical methods—theory & practice3rd ed., JA Kiernan. Butterworth-Heinemann, Oxford 1999; 156–158
   Google Scholar
• Lehr HA, van der Loos CM, Teeling P, Gown AM. Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem 1999; 47: 119–126
   PubMed Web of Science ®Google Scholar
• Moioli EK, Hong L, Mao JJ. Inhibition of osteogenic differentiation of human mesenchymal stem cells. Wound Repair Regen 2007; 15: 413–421
   PubMed Web of Science ®Google Scholar
• Mundy GR. The effects of TGF-beta on bone. Ciba Found Symp 1991; 157: 137–151
   PubMedGoogle Scholar
• Muraoka N, Shum L, Fukumoto S, Nomura T, Ohishi M, Nonaka K. Transforming growth factor-beta3 promotes mesenchymal cell proliferation and angiogenesis mediated by the enhancement of cyclin D1, Flk-1, and CD31 gene expression during CL/Fr mouse lip fusion. Birth Defects Res A Clin Mol Teratol 2005; 73: 956–965
   PubMedGoogle Scholar
• Neal BC, Rodgers A, Clark T, Gray H, Reid IR, Dunn L, MacMahon SW. A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 2000; 71: 122–128
   PubMed Web of Science ®Google Scholar
• Nilsen R. Electronmicroscopic study of mineralization in induced heterotopic bone formation in guinea pigs. Scand J Dent Res 1980; 88: 340–347
   PubMedGoogle Scholar
• Nilsson OS, Persson PE. Heterotopic bone formation after joint replacement. Curr Opin Rheumatol 1999; 11: 127–131
   PubMedGoogle Scholar
• Opperman LA, Adab K, Gakunga PT. Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn 2000; 219: 237–247
   Google Scholar
• Pfeilschifter J, Seyedin SM, Mundy GR. Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. J Clin Invest 1988; 82: 680–685
   PubMed Web of Science ®Google Scholar
• Puzas JE, Miller MD, Rosier RN. Pathologic bone formation. Clin Orthop Relat Res 1989; 245: 269–281
   Google Scholar
• Ripamonti U, Crooks J, Matsaba T, Tasker J. Induction of endochondral bone formation by recombinant human transforming growth factor-beta2 in the baboon (Papio ursinus). Growth Factors 2000; 17: 269–285
   PubMed Web of Science ®Google Scholar
• Roelen BA, Dijke P. Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci 2003; 8: 740–748
   PubMedGoogle Scholar
• Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med 2002; 43: 346–353
   PubMed Web of Science ®Google Scholar
• ten Dijke P, Iwata KK, Goddard C, Pieler C, Canalis E, McCarthy TL, Centrella M. Recombinant transforming growth factor type beta 3: Biological activities and receptor-binding properties in isolated bone cells. Mol Cell Biol 1990; 10: 4473–4479
   PubMed Web of Science ®Google Scholar
• Toom A, Arend A, Gunnarsson D, Ulfsparre R, Suutre S, Haviko T, Selstam G. Bone formation zones in heterotopic ossifications: Histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3. Calcif Tissue Int 2007; 80: 259–267
   PubMed Web of Science ®Google Scholar
• Toom A, Haviko T, Rips L. Heterotopic ossification after total hip arthroplasty. Int Orthop 2001; 24: 323–326
   PubMedGoogle Scholar
• Vanden Bossche L, Vanderstraeten G. Heterotopic ossification: A review. J Rehabil Med 2005; 37: 129–136
   PubMed Web of Science ®Google Scholar
• Zhang R, Supowit SC, Hou X, Simmons DJ. Transforming growth factor-beta2 mRNA level in unloaded bone analyzed by quantitative in situ hybridization. Calcif Tissue Int 1999; 64: 522–526
   PubMedGoogle Scholar